Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JAC/DKI177PMID 15914489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention and Cure of Systemic Escherichia coli K1 Infection by Modification of the Bacterial Phenotype

  2004influential reference
• New ways to treat bacterial infections.

  2002cited by this paper
• Expression, mutagenesis and kinetic analysis of recombinant K1E endosialidase to define the site of proteolytic processing and requirements for catalysis

  2002cited by this paper
• Neonatal meningitis in England and Wales: 10 years on

  2001cited by this paper
• Characterization of the RcsC→YojN→RcsB Phosphorelay Signaling Pathway Involved in Capsular Synthesis in Escherichia coli

  2001cited by this paper
• Phosphorylation of Wzc, a Tyrosine Autokinase, Is Essential for Assembly of Group 1 Capsular Polysaccharides in Escherichia coli*

  2001cited by this paper
• Neonatal bacterial meningitis.

  2001cited by this paper
• Antimicrobial use and bacterial resistance.

  2000cited by this paper
• Complete nucleotide sequence of the gene encoding bacteriophage E endosialidase: implications for K1E endosialidase structure and function.

  1995cited by this paper
• Bacterial meningitis: Mechanisms of disease and therapy

  1995cited by this paper
• Capsular sialyl chains ofEscherichia coli K1 mutants resistant to K1 phage

  1990cited by this paper
• The biologic significance of bacterial encapsulation.

  1990cited by this paper
• The role of bacterial polysaccharide capsules as virulence factors.

  1990cited by this paper
• Host factors in the resistance of newborn mice to K1 Escherichia coli infection.

  1988cited by this paper
• Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis

  1985cited by this paper
• Neuraminidase associated with coliphage E that specifically depolymerizes the Escherichia coli K1 capsular polysaccharide

  1985cited by this paper
• Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types

  1983cited by this paper
• Six widespread bacterial clones among Escherichia coli K1 isolates

  1983cited by this paper
• Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis

  1979cited by this paper
• Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli

  1977cited by this paper
• Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1

  1977influential reference
• Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from serum-sensitive and serum-resistant strains of Escherichia coli isolated from urinary-tract infections.

  1976cited by this paper

• Rapid Isolation and Genomic Characterization of Sewage-Derived Bacteriophages Targeting Multidrug-Resistant Avian Pathogenic Escherichia coli in Poultry

  2026cites this paper
• Absence of gut microbiota restoration following meropenem treatment in a systemic infection model

  2025cites this paper
• Modeling the phage properties best for therapy

  2025cites this paper
• Penetrating the biofilm barrier: characterization of Escherichia phage vB_EcoS-TPF103dw and harnessing depolymerase to combat Shiga toxin-producing Escherichia coli O103 biofilm

  2025cites this paper
• Advances in the production, purification, and concentration of bacteriophage bionanoparticles for biomedical applications.

  2025cites this paper
• Phage-mediated TLR2 signaling attenuates intracellular Mycobacterium abscessus survival in macrophages

  2025cites this paper
• Phage-derived polysaccharide depolymerase potentiates ceftazidime efficacy against Acinetobacter baumannii pneumonia via low-serum-dependent mechanisms.

  2024cites this paper
• A novel Enterococcus faecalis bacteriophage Ef212: biological and genomic features

  2024cites this paper
• Translating bacteriophage-derived depolymerases into antibacterial therapeutics: Challenges and prospects

  2023cites this paper
• Therapeutic Effect of Portulaca oleracea‎‎‎ Against Diarrhea ‎Induced by Escherichia coli in Male Rats

  2023cites this paper
• Potential of phage depolymerase for the treatment of bacterial biofilms

  2023influential citation
• Genome editing for phage design and uses for therapeutic applications.

  2023cites this paper
• Evolutionary and functional history of the Escherichia coli K1 capsule

  2023cites this paper
• Isolation and Characterization of a Novel Phage Collection against Avian-Pathogenic Escherichia coli

  2023cites this paper
• Paving the way forward: Escherichia coli bacteriophages in a One Health approach

  2023cites this paper
• Bacteriophages: Potential Biocontrol Agents and Treatment Options for Bacterial Pathogens

  2022cites this paper
• A newly isolated bacteriophage vB8388 and its synergistic effect with aminoglycosides against multi-drug resistant Klebsiella oxytoca strain FK-8388.

  2022cites this paper
• Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans

  2022cites this paper
• Phage-mimicking nanoagents for rapid depolymerase specificity screening against multidrug resistant bacteria.

  2022cites this paper
• Resistance of Xanthomonas oryzae pv. oryzae to Lytic Phage X2 by Spontaneous Mutation of Lipopolysaccharide Synthesis-Related Glycosyltransferase

  2022cites this paper
• Deconstructing the Phage–Bacterial Biofilm Interaction as a Basis to Establish New Antibiofilm Strategies

  2022cites this paper
• The Use of the λ Bacteriophage to Neutralize the Pathogenic Effects of Shiga Toxins from Escherichia Coli to Combat Antimicrobial Resistance: A Research Protocol

  2021cites this paper
• The Role of Bacterial Biofilms in Chronic Infectious Processes and the Search for Methods to Combat Them

  2021cites this paper
• Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application

  2021cites this paper
• Identification of a phage-derived depolymerase specific for KL64 capsule of Klebsiella pneumoniae and its anti-biofilm effect

  2021cites this paper
• A Novel Tail-Associated O91-Specific Polysaccharide Depolymerase from a Podophage Reveals Lytic Efficacy of Shiga Toxin-Producing Escherichia coli

  2020cites this paper
• Clinical Treatment of UTI in Rats Induced by Pathogenic E. Coli

  2020cites this paper
• Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli

  2020cites this paper
• Isolation and Characterization of Two Klebsiella pneumoniae Phages Encoding Divergent Depolymerases

  2020cites this paper
• Alternative antiinfective therapy

  2020cites this paper
• Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy

  2019cites this paper
• Phage Therapy in the Postantibiotic Era

  2019cites this paper
• The Capsule Depolymerase Dpo48 Rescues Galleria mellonella and Mice From Acinetobacter baumannii Systemic Infections

  2019cites this paper
• Corrigendum: The Capsule Depolymerase Dpo48 Rescues Galleria mellonella and Mice From Acinetobacter baumannii Systemic Infections

  2019cites this paper
• Three Capsular Polysaccharide Synthesis-Related Glucosyltransferases, GT-1, GT-2 and WcaJ, Are Associated With Virulence and Phage Sensitivity of Klebsiella pneumoniae

  2019cites this paper
• K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis

  2019influential citation
• Bacteriophage Proteins as Antimicrobials to Combat Antibiotic Resistance

  2019cites this paper
• A Novel Polysaccharide Depolymerase Encoded by the Phage SH-KP152226 Confers Specific Activity Against Multidrug-Resistant Klebsiella pneumoniae via Biofilm Degradation

  2019cites this paper
• Characterization of a novel Yersinia ruckeri serotype O1-specific bacteriophage with virulence-neutralizing activity.

  2019cites this paper
• Phage-encoded K2 capsule depolymerase is highly stable, refractory to resistance and protects larvae and mice from Acinetobacter baumannii sepsis

  2019influential citation
• Bakteriofagi jako kluczowy element w regulacji liczebności, zmienności i bioróżnorodności bakterii

  2018cites this paper
• Antibiotic Therapy Using Phage Depolymerases: Robustness Across a Range of Conditions

  2018cites this paper
• Genomic and Biochemical Characterization of Acinetobacter Podophage Petty Reveals a Novel Lysis Mechanism and Tail-Associated Depolymerase Activity

  2018cites this paper
• Mechanism of methicillin-resistant Staphylococcus aureus biofilm degradation by bacteriophages

  2018cites this paper
• In vitro antibacterial and antidiarraheic activity of root bark extract of Anogeissus leiocarpa (Combretaceae) during an experimental bacterial diarrhea induced by Escherichia coli extended-spectrum -lactamases (ESBL) in albino Wistar rats

  2018cites this paper
• Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?

  2018cites this paper
• Biology and Genomics of an Historic Therapeutic Escherichia coli Bacteriophage Collection

  2017cites this paper
• Bacteriophages and their derivatives for the treatment and control of food-producing animal infections

  2017cites this paper
• Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic Escherichia coli

  2017cites this paper
• Non-invasive three-dimensional imaging of Escherichia coli K1 infection using diffuse light imaging tomography combined with micro-computed tomography.

  2017cites this paper
• Bacteriophages and Their Immunological Applications against Infectious Threats

  2017cites this paper
• Therapeutic Application of Phage Capsule Depolymerases against K1, K5, and K30 Capsulated E. coli in Mice

  2017cites this paper
• Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process

  2017cites this paper
• Bacteriophage-encoded depolymerases: their diversity and biotechnological applications

  2016cites this paper
• Pathoadaptive Mutations of Escherichia coli K1 in Experimental Neonatal Systemic Infection

  2016cites this paper
• Threading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.

  2016cites this paper
• Capsule-Targeting Depolymerase, Derived from Klebsiella KP36 Phage, as a Tool for the Development of Anti-Virulent Strategy

  2016cites this paper
• In Vitro Antibacterial Activities of Cranberry Extract against E . coli O 157 : H 7 in Urinary Tract Infected Rats

  2015influential citation
• Parenteral Administration of Capsule Depolymerase EnvD Prevents Lethal Inhalation Anthrax Infection

  2015cites this paper
• The Genotoxin Colibactin Is a Determinant of Virulence in Escherichia coli K1 Experimental Neonatal Systemic Infection

  2015cites this paper
• Bacteriophages: their use in the treatment of infections in the future

  2015cites this paper
• Endosialidases: Versatile Tools for the Study of Polysialic Acid.

  2015cites this paper
• Bacteriophages and Phage-Derived Proteins – Application Approaches

  2015cites this paper
• Role of the Pre-neck Appendage Protein (Dpo7) from Phage vB_SepiS-phiIPLA7 as an Anti-biofilm Agent in Staphylococcal Species

  2015cites this paper
• Bioluminescent Imaging Reveals Novel Patterns of Colonization and Invasion in Systemic Escherichia coli K1 Experimental Infection in the Neonatal Rat

  2015cites this paper
• [Phage associated polysaccharide depolymerases - characteristics and application].

  2015cites this paper
• Antimicrobial bacteriophage-derived proteins and therapeutic applications

  2015cites this paper
• Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

  2014cites this paper
• Bacteriophages and their enzymes in biofilm control.

  2014cites this paper
• Identification of Capsular Types in Carbapenem-Resistant Klebsiella pneumoniae Strains by wzc Sequencing and Implications for Capsule Depolymerase Treatment

  2014cites this paper
• Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection

  2014cites this paper
• Bacteriophages as an alternative strategy for fighting biofilm development.

  2014cites this paper
• Lifting the Mask: Identification of New Small Molecule Inhibitors of Uropathogenic Escherichia coli Group 2 Capsule Biogenesis

  2014cites this paper
• Chapter 17 – Capsule and lipopolysaccharide

  2013cites this paper
• Altered Innate Defenses in the Neonatal Gastrointestinal Tract in Response to Colonization by Neuropathogenic Escherichia coli

  2013cites this paper
• Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an “immunodiverse” developmental state

  2013cites this paper
• Evolutionary principles and synthetic biology: avoiding a molecular tragedy of the commons with an engineered phage

  2012cites this paper
• Learning from Bacteriophages - Advantages and Limitations of Phage and Phage-Encoded Protein Applications

  2012cites this paper
• 8 Application of Therapeutic Phages in Medicine

  2012cites this paper
• Bacteriophages in Health and Disease

  2012cites this paper
• Application of Therapeutic Phages in Medicine

  2012cites this paper
• Properties of the peptidoglycan-degrading enzyme of the Pseudomonas aeruginosa ϕPMG1 bacteriophage

  2011cites this paper
• [The properties of the Pseudomonas aeruginosa bacteriophage phiPMG1].

  2011cites this paper
• Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1.

  2010cites this paper
• High-Throughput Identification of Chemical Inhibitors of E. coli Group 2 Capsule Biogenesis as Anti-Virulence Agents

  2010cites this paper
• Genome Annotation and Intraviral Interactome for the Streptococcus pneumoniae Virulent Phage Dp-1

  2010cites this paper
• The Anthrax Capsule: Role in Pathogenesis and Target for Vaccines and Therapeutics

  2010cites this paper
• Search for destruction factors of bacterial biofilms: Comparison of phage properties in a group of Pseudomonas putida bacteriophages and specificity of their halo-formation products

  2009cites this paper
• Characterisation of bacteriophage-derived tailspike and tail fibre proteins

  2008cites this paper
• Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1.

  2008cites this paper
• Identification of amino acid residues at the active site of endosialidase that dissociate the polysialic acid binding and cleaving activities in Escherichia coli K1 bacteriophages.

  2007cites this paper
• Treatment of Experimental Anthrax with Recombinant Capsule Depolymerase

  2007cites this paper
• Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide

  2007cites this paper
• Poly-γ-Glutamate Capsule-Degrading Enzyme Treatment Enhances Phagocytosis and Killing of Encapsulated Bacillus anthracis

  2006cites this paper
• Towards rational treatment of bacterial infections during extended space travel.

  2005cites this paper